Sign up to save your podcasts
Or
Share #63 From writing a newspaper column at age 7 to becoming a BioTech CEO: Cary Claiborne Sr.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#63 From writing a newspaper column at age 7 to becoming a BioTech CEO: Cary Claiborne Sr.
Cary Claiborne Sr. is the CEO of Adial Pharmaceuticals and member of the board. He also sits on the board for Nuerosense Therapeutics and CytRx. Cary holds an MBA from Villanova University. In this episode Cary shares how his interest in finance at an early age led him to become the CFO of a small biotech that led him to where he is today.
Support the show: https://www.buymeacoffee.com/biotechiq
Books that Cary referenced:
Holy Bible - https://amzn.to/3Y6um4W
Control Your Destiny or Someone Else Will - https://amzn.to/3ITDuWc
Check me out on LinkedIn https://www.linkedin.com/in/ammonr/
View all episodes
By Ammon RiveraCary Claiborne Sr. is the CEO of Adial Pharmaceuticals and member of the board. He also sits on the board for Nuerosense Therapeutics and CytRx. Cary holds an MBA from Villanova University. In this episode Cary shares how his interest in finance at an early age led him to become the CFO of a small biotech that led him to where he is today.
Support the show: https://www.buymeacoffee.com/biotechiq
Books that Cary referenced:
Holy Bible - https://amzn.to/3Y6um4W
Control Your Destiny or Someone Else Will - https://amzn.to/3ITDuWc
Check me out on LinkedIn https://www.linkedin.com/in/ammonr/